Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants.

Levinson-Castiel R, Merlob P, Linder N, Sirota L, Klinger G.

Arch Pediatr Adolesc Med. 2006 Feb;160(2):173-6.

PMID:
16461873
2.

Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome.

Klinger G, Merlob P.

Isr J Psychiatry Relat Sci. 2008;45(2):107-13. Review.

3.

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.

Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, Wisner KL.

JAMA. 2005 May 18;293(19):2372-83. Review.

PMID:
15900008
4.

Fluoxetine during pregnancy: impact on fetal development.

Morrison JL, Riggs KW, Rurak DW.

Reprod Fertil Dev. 2005;17(6):641-50. Review.

PMID:
16263070
5.

Safety of newer antidepressants in pregnancy.

Way CM.

Pharmacotherapy. 2007 Apr;27(4):546-52. Review.

PMID:
17381382
6.

Problems associated with long-term treatment with selective serotonin reuptake inhibitors.

Moret C, Isaac M, Briley M.

J Psychopharmacol. 2009 Nov;23(8):967-74. doi: 10.1177/0269881108093582. Epub 2008 Jul 17. Review.

PMID:
18635702
7.

Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs).

Ellfolk M, Malm H.

Reprod Toxicol. 2010 Sep;30(2):249-60. doi: 10.1016/j.reprotox.2010.04.015. Epub 2010 May 4. Review.

PMID:
20447455
8.

Safety of selective serotonin reuptake inhibitors in pregnancy.

Alwan S, Friedman JM.

CNS Drugs. 2009;23(6):493-509. doi: 10.2165/00023210-200923060-00004. Review.

PMID:
19480468
9.

Fetal and neonatal effects of maternal drug treatment for depression.

Belik J.

Semin Perinatol. 2008 Oct;32(5):350-4. doi: 10.1053/j.semperi.2008.08.001. Review.

PMID:
18929158
10.

Neonatal drug addiction.

Fabris C, Prandi G, Perathoner C, Soldi A.

Panminerva Med. 1998 Sep;40(3):239-43. Review.

PMID:
9785924
11.

Selective serotonin-reuptake inhibitors in pregnancy and lactation.

Baum AL, Misri S.

Harv Rev Psychiatry. 1996 Sep-Oct;4(3):117-25. Review.

PMID:
9384984
12.

Selective serotonin reuptake inhibitor poisoning: An evidence-based consensus guideline for out-of-hospital management.

Nelson LS, Erdman AR, Booze LL, Cobaugh DJ, Chyka PA, Woolf AD, Scharman EJ, Wax PM, Manoguerra AS, Christianson G, Caravati EM, Troutman WG.

Clin Toxicol (Phila). 2007 May;45(4):315-32. Review.

PMID:
17486478
13.

Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?

Koren G, Matsui D, Einarson A, Knoppert D, Steiner M.

CMAJ. 2005 May 24;172(11):1457-9. Review. No abstract available.

14.

Neonatal abstinence syndrome.

Kocherlakota P.

Pediatrics. 2014 Aug;134(2):e547-61. doi: 10.1542/peds.2013-3524. Review.

15.

Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy.

Davis RL, Rubanowice D, McPhillips H, Raebel MA, Andrade SE, Smith D, Yood MU, Platt R; HMO Research Network Center for Education, Research in Therapeutics.

Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1086-94. Review.

PMID:
17729378
16.

Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability.

Kolevzon A, Mathewson KA, Hollander E.

J Clin Psychiatry. 2006 Mar;67(3):407-14. Review.

PMID:
16649827
17.

Serotonin reuptake inhibitors in pregnancy and the risk of major malformations: a systematic review.

Bellantuono C, Migliarese G, Gentile S.

Hum Psychopharmacol. 2007 Apr;22(3):121-8. Review. Erratum in: Hum Psychopharmacol. 2007 Aug;22(6):413.

PMID:
17397101
18.

Adverse effects in neonates exposed to SSRIs and SNRI in late gestation--Motherisk Update 2008.

Koren G, Boucher N.

Can J Clin Pharmacol. 2009 Winter;16(1):e66-7. Epub 2009 Jan 22. Review.

19.

[Adverse effects of selective serotonin reuptake inhibitors use during the third trimester of pregnancy and prevention guidelines].

Mejías C, Rodríguez-Pinilla E, Fernández Martín P, Martínez-Frías ML.

Med Clin (Barc). 2007 Apr 21;128(15):584-9. Review. Spanish.

PMID:
17462198
20.

The impact of prenatal drug exposure on the neonate.

Wagner CL, Katikaneni LD, Cox TH, Ryan RM.

Obstet Gynecol Clin North Am. 1998 Mar;25(1):169-94. Review.

PMID:
9547766
Items per page

Supplemental Content

Write to the Help Desk